Hartmann + Glucose, Viaflo (Potassium Chloride, Sodium Chloride, Calcium Chloride Dihydrate, Glucose, Sodium Lactate)

Hartmann + Glucose, Viaflo is indicated for clinical situations where fluid, electrolyte, and glucose replacement are required.

• Peri‑operative hydration and electrolyte maintenance during surgery.
• Treatment of hypoglycemia when rapid glucose delivery is needed.
• Replacement of fluid and electrolytes in patients with dehydration or loss due to vomiting, diarrhea, or burns.
• Support of patients receiving parenteral nutrition to maintain electrolyte balance.
• Management of electrolyte disturbances such as hyponatremia, hypokalemia, or hypocalcemia in acute care settings.

Adverse reactions to Hartmann + Glucose, Viaflo are generally infrequent but may occur during or after infusion.

Common

• Mild infusion‑site irritation or phlebitis.
• Transient hyperglycemia.
• Mild electrolyte imbalance (e.g., mild hypernatremia).
• Nausea or mild gastrointestinal discomfort.
• Headache.
• Low‑grade fever.

Serious

• Severe allergic reaction (anaphylaxis).
• Significant hyperkalemia.
• Severe hypernatremia.
• Fluid overload leading to pulmonary edema.
• Metabolic acidosis.
• Cardiac arrhythmia.

Clinicians should observe specific precautions when prescribing Hartmann + Glucose, Viaflo to ensure patient safety.

• Assess baseline electrolyte levels and blood glucose before initiation.
• Use caution in patients with renal impairment or congestive heart failure due to risk of fluid overload.
• Monitor serum potassium, sodium, and calcium during therapy, especially in high‑dose or prolonged infusions.
• Avoid rapid infusion rates that may cause osmotic shifts or cardiac irritation.
• Consider contraindications such as known hypersensitivity to any component of the solution.
• Adjust dosage in pediatric or elderly patients based on weight and clinical response.

Hartmann + Glucose, Viaflo may interact with other intravenous or oral agents; awareness of potential interactions helps prevent complications.

Avoid

• Concurrent administration of other potassium‑containing solutions that could cause hyperkalemia.
• Simultaneous infusion of high‑dose calcium salts, which may precipitate calcium phosphate.
• Use with hypertonic dextrose solutions that could exacerbate hyperglycemia.

Use with caution

• Co‑administration with diuretics, which may alter electrolyte balance and require closer monitoring.
• Concurrent use of insulin therapy, as rapid glucose delivery can affect blood sugar control.
• Administration alongside nephrotoxic drugs, where fluid shifts may impact renal function.